Tangqiang Wei
Papers
2
Total Citations
17
H-Index
2
About
Dr. Tangqiang Wei is a prominent urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques, particularly robotic-assisted radical cystectomy (RARC) for bladder cancer. His major contributions lie in demonstrating that RARC with intracorporeal urinary diversion (ICUD) offers superior perioperative outcomes—including smaller trauma and faster recovery—compared to traditional open or extracorporeal approaches. A 2020 systematic review and meta-analysis, his most cited work with 11 citations, synthesizes evidence that RARC reduces complications and hospital stays. In a companion study (6 citations), Dr. Wei establishes ICUD as a new standard, showing it lowers postoperative morbidity while maintaining oncologic efficacy. His research has helped shift clinical practice toward less invasive bladder cancer surgery, impacting both patient quality of life and surgical protocols. Dr. Wei’s work is widely referenced in urology guidelines and continues to influence the adoption of robotic techniques globally. For students and researchers, his studies exemplify how rigorous meta-analysis can drive evidence-based surgical innovation.
Research Focus
Key Achievements
Top Papers
- 1
- 2